Clinical Trials Logo

Clinical Trial Summary

In the proposed study, the investigators aim to investigate whether the existing ABAS-3 self-report questionnaire is suitable to be completed meaningfully by individuals who are perceived as having mild intellectual disability (55<IQ<85) based on cognitive impairment. Based on the participants' experiences and researchers' expertise, the investigators develop a 'more inclusive' self-report version. The investigators then look at the extent to which participants indicate that they understand this version better, based on user experiences and limited psychometric research. In doing so, the investigators also compare the outcomes of the self-report and informant-report variant.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05857592
Study type Interventional
Source Koraal
Contact
Status Completed
Phase N/A
Start date July 1, 2023
Completion date May 1, 2024